Autologous Blood for Full-thickness Macular Hole

Status Terminated

Clinical Trial Summary

Autologous blood for primary and recurrent holes

Clinical Trial Description

Utilizing whole autologous blood for closing both primary and recurrent holes. Here, we apply a drop of the taken whole blood over the hole, and the access blood will be aspirated on the macula with a silicon-tipped active back-flash cannula, to abolish all the possibilities of the fibrinogenic behavior of the whole blood composition, which might cause traction and recurrent hole formation. Therefore, only the hole will be filled with blood. The blood will be taken under completely sterile and aseptic conditions. The air infusion will be raised after the valve of one of the trocars will be removed, to allow the air current to dry the clot inside the hole rapidly. Then air gas exchange will be performed to allow the clot to remain away from intraocular fluids for one to two weeks and abolish the possibility of the clot being dissolved. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05494229
Study type	Interventional
Source	Ibinsina Modern Eye and Retina Center
Contact
Status	Terminated
Phase	N/A
Start date	September 1, 2022
Completion date	March 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05414994` - Assessment of the Ocular Microbiome in Health and Disease
Completed	`NCT04387292` - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic	N/A
Completed	`NCT05494242` - Single Superior ILM/ERM Flap for the FTMH.	N/A
Completed	`NCT04982484` - Reading Speed Improvements in Wet-AMD Patients After Ranibizumab Treatment
Completed	`NCT04683055` - Phaco-Trabeculotomy Vs Phaco-Trabeculectomy	N/A
Recruiting	`NCT06367517` - Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)
Completed	`NCT03766737` - Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children	N/A
Recruiting	`NCT04460001` - Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)	Phase 2/Phase 3
Completed	`NCT04917562` - Refractive Transepithelial Photo-keratectomy (T-PKR) in High Myopia
Completed	`NCT04771039` - Ocular Manifestations of Inflammatory Bowel Disease
Completed	`NCT03492242` - Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction
Withdrawn	`NCT04579458` - Assessment of COVID-19 in Tearfilm
Completed	`NCT03855462` - Evaluating Medium-chain Triglycerides as a Temporary Intraocular Tamponading Agent for Retinal Detachment	N/A
Recruiting	`NCT06293586` - Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery	N/A
Recruiting	`NCT06102265` - Effect Of Reusing the Operative Supplies On Cataract Surgery and Climate Change
Recruiting	`NCT03611387` - Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma
Completed	`NCT03499145` - Validation of the Utility of Ophthalmology Intelligent Diagnostic System